Over 200 HPV variants exist, many transmitted asymptomatically via intimate contact. Infected individuals often feel fine, unknowingly passing it on and fueling outbreaks.

While women face cervical cancer threats, men aren’t spared. Strains responsible for female cancers also drive penile, anal, and head-neck malignancies in males. Even non-cancerous genital warts cause significant hassle and stigma.

‘Vaccinating only girls is a critical oversight,’ asserts Dr. Pathak. Unprotected men remain at risk personally and become vectors for partners. Universal immunization disrupts transmission, a strategy adopted successfully worldwide.

Ideal timing? Pre-teens aged 9-14, leveraging peak immune efficacy for enduring protection with just two doses. Adults up to 45 can still benefit from three doses.

Available vaccines in India vary by strain coverage: imported Gardasil series for broad defense, and cost-effective Cervavac made domestically. Tailor selection with medical advice.

Safety is paramount; side effects mirror routine shots—temporary pain or fever, nothing serious. This low-risk measure promises high rewards in preventing HPV havoc.

Health authorities push for policy changes to include boys in national drives. Individuals should consult providers promptly, turning knowledge into action against this stealthy foe.